These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 16015001

  • 1. Bone alkaline phosphatase besides intact parathyroid hormone in hemodialysis patients--any advantage?
    Jorge C, Gil C, Possante M, Silva E, Andrade R, Santos N, Cruz A, Teixeira R, Ferreira A.
    Nephron Clin Pract; 2005; 101(3):c122-7. PubMed ID: 16015001
    [Abstract] [Full Text] [Related]

  • 2. [Alkaline phosphatase of bone origin in hemodialyzed patients. 110 assays].
    Ureña P, Prieur P, Pétrover M.
    Presse Med; 1996 Oct 05; 25(29):1320-5. PubMed ID: 8942941
    [Abstract] [Full Text] [Related]

  • 3. Secretion of parathyroid hormone oscillates depending on the change in serum ionized calcium during hemodialysis and may affect bone metabolism.
    Kitahara T, Ueki K, Kuroiwa T, Kaneko Y, Hiromura K, Nojima Y.
    Nephron Clin Pract; 2005 Oct 05; 101(1):c9-17. PubMed ID: 15886497
    [Abstract] [Full Text] [Related]

  • 4. Higher serum bone alkaline phosphatase as a predictor of mortality in male hemodialysis patients.
    Kobayashi I, Shidara K, Okuno S, Yamada S, Imanishi Y, Mori K, Ishimura E, Shoji S, Yamakawa T, Inaba M.
    Life Sci; 2012 Jan 30; 90(5-6):212-8. PubMed ID: 22154904
    [Abstract] [Full Text] [Related]

  • 5. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
    Ueda M, Inaba M, Okuno S, Maeno Y, Ishimura E, Yamakawa T, Nishizawa Y.
    Life Sci; 2005 Jul 22; 77(10):1130-9. PubMed ID: 15978265
    [Abstract] [Full Text] [Related]

  • 6. Correlation of bone alkaline phosphatase and iPTH with some basic biochemical markers in predialysis and dialysis patients.
    Milinković NL, Majkic-Singh NT, Ignjatović SD, Lezaić VD, Pejanović SD, Jovanovic DB.
    Clin Lab; 2012 Jul 22; 58(7-8):747-53. PubMed ID: 22997975
    [Abstract] [Full Text] [Related]

  • 7. Parathyroid hormone levels, calcium-channel blockers, and the dyslipidemia of nondiabetic hemodialysis patients.
    Zanos S, Mitsopoulos E, Sakellariou G.
    Ren Fail; 2005 Jul 22; 27(2):163-9. PubMed ID: 15807180
    [Abstract] [Full Text] [Related]

  • 8. Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients.
    Ureña P, Hruby M, Ferreira A, Ang KS, de Vernejoul MC.
    J Am Soc Nephrol; 1996 Mar 22; 7(3):506-12. PubMed ID: 8704118
    [Abstract] [Full Text] [Related]

  • 9. The impact of baseline intact parathyroid hormone levels on severity of primary hyperparathyroidism and outcomes in patients undergoing surgery.
    Kandil E, Alabbas H, Tufaro AP, Carson KA, Tufano RP.
    Arch Otolaryngol Head Neck Surg; 2010 Feb 22; 136(2):147-50. PubMed ID: 20157060
    [Abstract] [Full Text] [Related]

  • 10. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H, Baradaran A, Naderi AS.
    Acta Med Austriaca; 2004 Aug 22; 31(3):67-72. PubMed ID: 15515479
    [Abstract] [Full Text] [Related]

  • 11. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H, Baradaran A.
    J Ayub Med Coll Abbottabad; 2004 Aug 22; 16(2):3-8. PubMed ID: 15455608
    [Abstract] [Full Text] [Related]

  • 12. Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis.
    Greenbaum LA, Benador N, Goldstein SL, Paredes A, Melnick JZ, Mattingly S, Amdahl M, Williams LA, Salusky IB.
    Am J Kidney Dis; 2007 Jun 22; 49(6):814-23. PubMed ID: 17533024
    [Abstract] [Full Text] [Related]

  • 13. Effects of calcitriol on type 5b tartrate-resistant acid phosphatase and interleukin-6 in secondary hyperparathyroidism.
    Lu KC, Tseng CF, Wu CC, Yeung LK, Chen JS, Chao TY, Janckila AJ, Yam LT, Chu P.
    Blood Purif; 2006 Jun 22; 24(5-6):423-30. PubMed ID: 16888370
    [Abstract] [Full Text] [Related]

  • 14. Serum pyridinoline as a specific marker of collagen breakdown and bone metabolism in hemodialysis patients.
    Ureña P, Ferreira A, Kung VT, Morieux C, Simon P, Ang KS, Souberbielle JC, Segre GV, Drüeke TB, De Vernejoul MC.
    J Bone Miner Res; 1995 Jun 22; 10(6):932-9. PubMed ID: 7572317
    [Abstract] [Full Text] [Related]

  • 15. Bio-intact parathyroid hormone and intact parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism receiving intravenous calcitriol therapy.
    Fujimori A, Sakai M, Yoshiya K, Shin J, Kim JI, Inaba Y, Miyamoto T, Inoue S, Fukagawa M.
    Ther Apher Dial; 2004 Dec 22; 8(6):474-9. PubMed ID: 15663547
    [Abstract] [Full Text] [Related]

  • 16. [Interest of bone alkaline phosphatase in hemodialysis patients].
    Helal I, Bahlous A, El Younsi F, Ben Hamida F, Abdelmoula J, Belkahia C, Kheder A.
    Tunis Med; 2008 May 22; 86(5):427-30. PubMed ID: 19469294
    [Abstract] [Full Text] [Related]

  • 17. Initial dosing of paricalcitol based on PTH levels in hemodialysis patients with secondary hyperparathyroidism.
    Mitsopoulos E, Zanos S, Ginikopoulou E, Kyriklidou P, Meimaridou D, Sakellariou G.
    Am J Kidney Dis; 2006 Jul 22; 48(1):114-21. PubMed ID: 16797393
    [Abstract] [Full Text] [Related]

  • 18. Impact of lowering dialysate calcium concentration on serum bone turnover markers in hemodialysis patients.
    Hamano T, Oseto S, Fujii N, Ito T, Katayama M, Horio M, Imai E, Hori M.
    Bone; 2005 May 22; 36(5):909-16. PubMed ID: 15794928
    [Abstract] [Full Text] [Related]

  • 19. Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide.
    Sriussadaporn S, Phoojaroenchanachai M, Ploybutr S, Plengvidhya N, Peerapatdit T, Nitiyanant W, Vannasaeng S, Vichayanrat A.
    J Med Assoc Thai; 2007 Apr 22; 90(4):663-71. PubMed ID: 17487119
    [Abstract] [Full Text] [Related]

  • 20. [Serum osteocalcin in children with chronic renal insufficiency].
    Peco-Antić A, Nastić-Mirić D, Milikić V, Babić D, Pejcić I, Kostić M, Paripović V, Jovanović O, Kruscić D, Mancić J.
    Srp Arh Celok Lek; 1996 Apr 22; 124(9-10):227-31. PubMed ID: 9102853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.